Dr. Sonexay Siphandone has been elected Prime Minister of Laos after receiving nearly 100% of votes from the National Assembly.
Pathomics Health and MAHSA Health sign MOU to launch Joint Centre for Research and Diagnostics for Precision Wellness and Clinical Research

The collaboration focuses on health and wellness screening with MAHSA Health to optimise the wellbeing of individuals in Malaysia. Clinical research will also be part of the partnership to further support clinicians in their clinical care for patients across the MAHSA Health’s network of hospitals and clinics.
Combined expertise from both parties to make a significant impact on the health and wellness of MAHSA Health’s patients and cement the Joint Centre’s position as a Centre of Excellence for genomics to support MAHSA Health in its advancement of health care services, research, and innovation in ASEAN.
The changing lifestyles of the affluent middle-class lead to the disease burden shifting from communicable diseases to non-communicable diseases (NCDs) such as diabetes, cardiovascular disease, and cancer. As the middle class becomes more aware of NCDs, there is a higher demand for health check-ups and more effective diagnostics. With the use of genomics testing advancement, individuals can now better uncover their underlying risks profile to NCDs and take more proactive actions to better manage their health.
For the past 10 years, cardiovascular disease (CVD) is among the leading causes of death and morbidity in Malaysia . CVDs ranked first among the ten principal causes of death in government hospitals (21.65%) and ranked second in private hospitals (23.79%). While elderly is at risk of developing CVDs, studies suggest that 1 in 5 heart attack patients are younger than 40 years old. It is a myth that heart attacks only occur to the old. Young adults should take proactive care of their health.1
Malaysia has one of the highest incidences of diabetes in the world. According to the Malaysian 2019 national survey report, for ≥18 years old age group, 3.6 million adults had diabetes, 49% (3.7 million) cases were undiagnosed. It is estimated that diabetes can affect 7 million of Malaysian adults, posing a major public health risk with a diabetes prevalence of 31.3%. 2
Cancer is among the most common causes of deaths in Malaysia. Most cases are only discovered at late stages resulting in poor therapy outcomes. Rising direct and indirect costs of cancers impact on both the patient and family. Approximately 45% of Malaysian cancer survivors spend over 30% of their household income for cancer care within the first year of diagnosis. Early diagnosis of cancer can lead to a better likelihood of effective treatment which in turn can increase the chances of survival, less morbidity and less therapy costs.3
In 2020, 49,000 new cancer cases were estimated in Malaysia and projected to rise to more than 66,000 per year by 2030. Approximately 50% of total cancer cases are due to breast, colorectal and lung cancers in Malaysia. The leading causes of death for Malaysian women suffering from cancer is breast and cervical cancer. The screening uptake and frequency for breast, cervical, colorectal, and prostate cancers can be better. The poor response to cancer screening can be due to a lack of awareness on the available screening methods, support from family members and family doctors.
“With the advancement of medical science, everyone should have access to precision wellness and be empowered to lead heathier lifestyle and better therapy outcomes with early interventions. The genomics profiling test is a start for an individual to better understand one’s health risks profile for Cardiovascular, Cancer and Diabetes. We have a network of healthcare professionals who will support those with high risk of NCD to take proactive family planning measures, lifestyle changes to better lower their risks. With the diverse health screening tests options, it also acts as a compass for family physicians to personalise health screening tests to better meet their patients’ unique health profile. ” Michael Tan, Director of Pathomics Health.
MAHSA Health Sdn Bhd is a Malaysia-grown company, part of MAHSA Group of Companies, which is determined to be a revolutionary leader in healthcare. Since its inception in 2017, MAHSA Health has been striving to be in the forefront of primary healthcare, focusing on family health and wellness.
Pathomics Health focuses on advanced precision medicine diagnostics & digital healthcare solutions–in particular, but not limited to cancer. Since 2016, Pathomics Health has been driving excellence to unlock actionable genomics insights to enhance patient care. Pathomics Health forged its first public private partnership with University of Malaya in 2016. In 2021, Pathomics Health was appointed by Qiagen as its preferred laboratory outsourcing next generation sequencing research solutions partner for ASEAN markets. In 2022, Pathomics Health sets up its clinical diagnostics and research facilities in Singapore, focusing on Infectious Diseases and Oncology and hereby expanding its operations from Malaysia. Pathomics Health supports the acceleration of healthcare and life science research in ASEAN markets by providing outsourcing research testing services in addition to its clinical diagnostics services. In 2022, Singviva, an insurtech partner of MY IRC Sdn Bhd, has appointed Pathomics Health as its sole genomics risk profiling diagnostics lab partner for their policy holders. To find out more about Pathomics Health’s genomics profiling tests, visit pathgene.asia.
With its latest collaboration with MAHSA, Pathomics health will provide the Malaysian public and medical tourists visiting Malaysia access to its advance health screening tools beyond genomics profiling tests services offered across MAHSA health network of primary care clinics and hospital. Pathomics health and MAHSA are committed to improve primary healthcare and push the frontiers of clinical research and advanced digital healthcare solutions in precision wellness, infectious diseases screening and pharmacogenomics.
References:
1. Int. J. Environ. Res. Public Health 2021, 18, 7941. https://doi.org/10.3390/ijerph18157941
2. Akhtar S, Nasir JA, Ali A, Asghar M, Majeed R, et al. (2022) Prevalence of type-2 diabetes and prediabetes in Malaysia: A systematic review and meta-analysis. PLOS ONE 17(1): e0263139. https://doi.org/10.1371/journal.pone.0263139
3. Ministry of Health Malaysia (2021). National Strategic Plan for Cancer Control Programme 2021-2025.
4. Cancer in My Community: Addressing Increasing Cancer Cases in Malaysia. Cancer.Net. 17 Feb 2022. Mastura Md Yusof, Wan Zamaniah Wan Ishak. Accessed on 1/09/2022.
For more information on Pathomics Health, visit website at www.pathomicshealth.com.
Hashtag: #pathomicshealth #pathgene #nextgenerationsequencing #diagnostics #healthtech #ngs #genomics #cardiovascular #oncology #cancer #diabetes #mahsa #mahsahealth #healthscreening #healthassessment #healthandwellness #wellness #healthylifestyle #investhealth ##DatinDrMayaKumutha
The issuer is solely responsible for the content of this announcement.
Pathomics Health Pte Ltd
Pathomics Health, a diagnostics and research service provider, focuses on advanced precision diagnostics and digital healthcare solutions. Its full-service CAP (College of American Pathologists) –compliant laboratory deploys cutting-edge technologies that are clinically validated by international bodies such as FDA and CE-IVD. Equipped with a multi-disciplinary team of experts, Pathomics Health’s customers and patients receive high-quality diagnostics reports for better management of patient care and health outcomes. In 2017, the University of Malaya and Pathomics Health established GEMS@UM, a public-private partnership, to provide patients access to cost-effective precision medicine. In 2019, Pathomics Health established its regional headquarters in Singapore. In 2022, Pathomics Health is expanding its laboratory operations from Malaysia to Singapore.
Spackman Media Group Artist Wi Ha-Jun Wins Rising Star Award In 2023 Korea First Brand Awards
- Spackman Media Group artist Wi Ha-jun awarded the Rising Star Award in the 2023 Korea First Brand Awards conducted by the Korea Consumer Forum
- Award follows Wi Ha-jun’s latest chart-topping Netflix drama, LITTLE WOMEN, which ranked first in Taiwan, Indonesia and Japan and 8th globally on Netflix, according to Flixpatrol.com as of October 8, 2022
- Previously, Wi Ha-jun starred in the original Korean series, SQUID GAME (2021), the #1 Netflix show across over 90 countries, including the US and Korea
SINGAPORE – Media OutReach – 30 December 2022 – Spackman Entertainment Group Limited (the “Group“), one of Korea’s leading entertainment production groups founded in 2011 by media & technology investor Charles Spackman, wishes to announce that Wi Ha-jun of MSteam Entertainment Co., Ltd. (“MSteam“), a wholly-owned subsidiary of the Group’s associated company, Spackman Media Group Limited (“Spackman Media Group“), was awarded the Rising Star Award in the 2023 Korea First Brand Awards conducted by the Korea Consumer Forum on December 29, 2022[1].
Conducted annually by the Korea Consumer Forum, the Korea First Brand Awards recognizes the brand reputation of various idols, actors and groups in the local entertainment sector and provides brands with a frame of reference on the popularity and loyalty of celebrities amongst consumers.
Spackman Media Group artist Wi Ha-jun’s latest Netflix drama, LITTLE WOMEN, which was filmed in Korea and Singapore, took the top spot in Taiwan, Indonesia and Japan and ranked 8th globally on Netflix, according to Flixpatrol.com as of October 8, 2022. The series featured iconic landmarks in Singapore such as Marina Bay Sands and The Fullerton Hotel.
In February 2022, Wi Ha-jun of Spackman Media Group was selected as the South Korea ambassador for Swiss luxury watchmaker, TAG Heuer. He was appointed as the ambassador for his hometown, Wando-gun of South Korea in January 2022. Previously, Wi Ha-jun starred in the original Korean series, SQUID GAME (2021), the #1 Netflix show across over 90 countries, including the US and Korea. Through his role as Hwang Jun-ho, a policeman in SQUID GAME (2021), Wi Ha-jun has emerged as an internationally recognized actor.
Wi Ha-jun also starred in highly popular K-drama BAD AND CRAZY (2021), which reached first place in viewership ratings for consecutive weekends after its release on 17 December 2021.
Wi Ha-jun was also selected as the brand ambassador for the American premium casual brand BEENTRILL and released a beauty pictorial with YSL beauty in December 2021. He also headlined in the Korean crime thriller film, MIDNIGHT (2021), which received the Best Feature Award at the 13th UK Grimmfest Film Festival.
In addition to Wi Ha-jun, MSteam represents iconic Korean actress Son Ye-jin, who starred in hit romance drama CRASH LANDING ON YOU (2020), and top actress Lee Min-jung, who won the Top Excellence Award at the 2020 APAN Star Awards.
Hashtag: #SpackmanEntertainmentGroup
The issuer is solely responsible for the content of this announcement.
About Spackman Entertainment Group Limited
Spackman Entertainment Group Limited (“SEGL” or the “Company“), and together with its subsidiaries, (the “Group“), is one of Korea’s leading entertainment production groups. SEGL is primarily engaged in the independent development, production, presentation, and financing of theatrical motion pictures in Korea.
The Company was founded in 2011 by renowned media and technology investor Charles Spackman who served as the Company’s Executive Chairman until 2017. For the past two decades, Mr. Charles Spackman has been a powerhouse in the Korean entertainment industry starting in the early 2000’s with the pioneering success of Sidus Pictures, the largest movie production company at the time and the first to be listed in Korea. Mr. Spackman is also the Founder, Chairman and Chief Executive Officer of the global investment firm, Spackman Group. For more information, please visit http://www.charlesspackman.com and
https://spackman-group.com/charles-spackman.
Since its founding, SEGL had produced more than 30 major motion pictures including a number of the highest grossing and award-winning films in Korea, namely #ALIVE (2020), CRAZY ROMANCE (2019), DEFAULT (2018), MASTER (2016), THE PRIESTS (2015), SNOWPIERCER (2013), COLD EYES (2013) and ALL ABOUT MY WIFE (2012).
Our films are theatrically distributed and released in Korea and overseas markets, as well as for subsequent post-theatrical worldwide release in other forms of media, including online streaming, cable TV, broadcast TV, IPTV, video-on-demand, and home video/DVD, etc. Generally, we release our motion pictures into wide-theatrical exhibition initially in Korea, and then in overseas and ancillary markets.
The Group also invests into and produces Korean television dramas. In addition to our content business, we also own equity stakes in entertainment-related companies and film funds that can financially and strategically complement our existing core operations. SEGL is listed on the Catalist of the Singapore Exchange Securities Trading Limited under the ticker 40E.
Production Labels
SEGL owns a 100% equity interest in Studio Take Co., Ltd. (“Studio Take“) which produced STONE SKIPPING (2020) and THE BOX (2021). Its latest film, A MAN OF REASON, is set to be screened theatrically and digitally in North America in the first quarter of 2023 and at theatres in Korea in the fourth quarter of 2022 or first quarter of 2023. A MAN OF REASON premiered in the US at the 42nd Hawaii International Film Festival. The film was also invited to the 47th Toronto International Film Festival, the largest film festival in North America, and the 55th Sitges Film Festival, one of the world’s top three genre film festivals. Studio Take shall also release an upcoming film, THE GUEST, in 2023 tentatively.
SEGL owns Novus Mediacorp Co., Ltd. (“Novus Mediacorp“), an investor, presenter, and/or post-theatrical distributor for a total of 80 films (59 Korean and 21 foreign) including OKAY MADAM (2020), LONG LIVE THE KING (2019), MY FIRST CLIENT (2019), ROSE OF BETRAYAL (2018), THE OUTLAWS (2017) and SECRETLY, GREATLY (2013), which was one of the biggest box office hits of 2013 starring Kim Soo-hyun of MY LOVE FROM THE STARS (2013), as well as FRIEND 2: THE GREAT LEGACY (2013). In 2012, Novus Mediacorp was also the post-theatrical rights distributor of ALL ABOUT MY WIFE (2012), a top-grossing romantic comedy produced by Zip Cinema. In 2018, THE OUTLAWS, co-presented by Novus Mediacorp broke the all-time highest Video On Demand (“VOD“) sales records in Korea. For more information, please visit http://novusmediacorp.com
The Company owns a 100% equity interest in Greenlight Content Limited (“Greenlight Content“) which is mainly involved in the business of investing into dramas and movies, as well as providing consulting services for the production of Korean content. Through the acquisition of Greenlight Content, the Group’s first co-produced drama, MY SECRET TERRIUS, starring top Korean star, So Ji Sub, achieved #1 in drama viewership ratings for its time slot and recorded double digits for its highest viewership ratings. Greenlight Content was one of the main investors of MY SECRET TERRIUS.
The Company owns a 100% equity interest in Simplex Films Limited (“Simplex Films“) which is an early stage film production firm. The maiden film of Simplex Films, JESTERS: THE GAME CHANGERS (2019), was released in Korea on 21 August 2019. Simplex Films has several line-up of films including HURRICANE BROTHERS (working title).
The Company owns a 20% equity interest in The Makers Studio Co. Ltd., which plans to produce and release four upcoming films, the first of which will be THE ISLAND OF THE GHOST’S WAIL, a comedy horror film.
Talent Representation
The Company holds an effective shareholding interest of 43.88% in Spackman Media Group Limited (“SMGL“). SMGL, a company incorporated in Hong Kong, together with its subsidiaries, is collectively one of the largest entertainment talent agencies in Korea in terms of the number of artists under management, including some of the top names in the Korean entertainment industry. SMGL operates its talent management business through renowned agencies such as SBD Entertainment Inc. (Son Suk-ku, Han Ji-hyun, Park Keun-rok), MSteam Entertainment Co., Ltd. (Son Ye-jin, Wi Ha-jun, Lee Min-jung, Ko Sung-hee, Lee Cho-hee), UAA&CO Inc. (Kim Sang-kyung) and Play Content Co., Ltd. (Hwang-hwi). Through these full-service talent agencies in Korea, SMGL represents and guides the professional careers of a leading roster of award-winning actors/actresses in the practice areas of motion pictures, television, commercial endorsements, and branded entertainment. SMGL leverages its unparalleled portfolio of artists as a platform to develop, produce, finance and own the highest quality of entertainment content projects, including theatrical motion pictures, variety shows and TV dramas. This platform also creates and derives opportunities for SMGL to make strategic investments in development stage businesses that can collaborate with SMGL artists. SMGL is an associated company of the Company. For more information, please visit http://www.spackmanmediagroup.com
The Company owns a 100% equity interest in Constellation Agency Pte. Ltd. (“Constellation Agency“). Constellation Agency, which owns The P Factory Co., Ltd. (“The P Factory“) and Platform Media Group Co., Ltd. (“PMG“), is primarily involved in the business of overseas agency for Korean artists venturing into the overseas market. The P Factory is an innovative marketing solutions provider specializing in event and branded content production. PMG is a talent management agency which represents and manages the careers of major artists in film, television, commercial endorsements and branded entertainment.
Strategic Businesses
The Company also operates a café-restaurant, Upper West, in the Gangnam district of Seoul and own a professional photography studio, noon pictures Co., Ltd.
For more details, please visit http://www.spackmanentertainmentgroup.com/
10 Confirmed Dead in Cambodian Casino Hotel Fire
The blaze that broke out at a casino in Poipet, Cambodia on Wednesday night claimed the lives of at least ten people, but the death toll is expected to rise.
Morocco and MRC Establish Educational Visitor Centre
Morocco has bolstered its status as the first Arab and African partner of the Mekong River Commission (MRC) by agreeing to deepen cooperation in various water and energy-related fields – including establishing an Educational Visitor Centre at the MRC Headquarters in Laos.
Police Hand Out Free Helmets, Water to Motorists Ahead of New Year
The traffic police on Route 13 South between Bolikhamxay and Khammouane Province have started distributing free helmets and water to passing motorists.
Prince Holding Group Supports NTU PEAK ASEAN
Survey indicates 100% of NTU participants considering Cambodia as a work destination post-graduation
PHNOM PENH, CAMBODIA – Media OutReach – 29 December 2022 – Prince Holding Group, one of the largest business groups in Cambodia, recently supported the Inaugural Nanyang Technological University (NTU) PEAK ASEAN, which brought together outstanding NTU students across the disciplines of Business, Humanities, Arts, Social Sciences and Engineering to the Kingdom of Cambodia for a two-week immersion. In addition, the NTU participants were teamed up with selected Cambodian students from CamEd Business School. Promising results from the Post Program Survey indicated that 100% of the NTU students are now considering Cambodia as a work destination after graduation.

Throughout the program, Prince Holding Group provided a conducive work and research environment to the participants, supported by the Group’s experienced mentors from two of its key entities – Belt Road Capital Management and Prince Real Estate Group.
Launched in 2017, NTU PEAK ASEAN is the extension of NTU PEAK Program, a three-week-long program conventionally organized in Singapore where students work together in teams to conduct research and surveys, and present viable solutions of real-world business challenges offered by participating corporate partners.
“Anchored on Design Thinking principles, NTU PEAK has been co-designed with industry partners to develop high-potential students who will become industry-relevant future leaders for the workplace and community,” said Desmond Woo, Deputy Director from Nanyang Technological University. “We would like to thank Prince Group for supporting our students throughout the program in Cambodia and to aid our students’ understanding of this fast-growing market.”
“The NTU PEAK ASEAN is a great opportunity to improve future Singapore industry leaders’ understanding of Cambodia,” said Gabriel Tan, Chief Communications Officer of Prince Holding Group. “Participants of the program interacted extensively with our international management team, impressing them with the extensive thought processes and solutions put forth in the final presentations. As an NTU Alumni, I certainly look forward to welcoming more participants and potential partners in the future” he added.
Human capital development has been a key focus for Prince Holding Group’s philanthropic arm, Prince Foundation. The Group is a regular supporter of Cambodia’s tertiary education sector and is working to identify the second batch of Chen Zhi Scholarship recipients. Through Prince Foundation, the Group awarded 100 scholarships to students in the 2021/22 term, supporting their higher education pursuit at top Cambodian Universities. Under the leadership and philanthropy of Neak Oknha Chen Zhi, Chairman of Prince Holding Group, Prince Foundation will continue to work towards strengthening human capital upskilling efforts in line with its education and youth development core pillar.
Hashtag: #PrinceHoldingGroup
The issuer is solely responsible for the content of this announcement.
FOMO Pay becomes SWIFT member and obtains dedicated BIC
This is a meaningful achievement for FOMO Pay in its pursuit to provide more efficient, secure, and reliable payment services. FOMO Pay will utilize the SWIFT Code to eliminate manual errors, reduce transfer fees and times, and streamline business transaction processes, thus enhancing its clients’ global collection and payout experiences.
SWIFT is the world’s leading financial messaging service provider, connecting more than 11,000 banks and financial institutions in over 200 countries. SWIFT Code is used to identify financial institutions and allow them to communicate with one another for seamless fund transfers.
Hashtag: #FOMOPay #SWIFT #BIC #SWIFTCode #Payments #Collections #Payouts #GlobalTransfer #FinancialInstitution
The issuer is solely responsible for the content of this announcement.
About FOMO Pay
Founded in 2015, FOMO Pay Pte Ltd is a major payment institution (License No. PS20200145) regulated under the Payment Services Act in Singapore, licensed by the Monetary Authority of Singapore (MAS) to conduct Cross-border Money Transfer Service, Domestic Money Transfer Service, Digital Payment Token Service, and Merchant Acquisition Service. The firm has become a leading one stop digital payment and banking solution provider and is currently building Asia’s first licensed gateway helping institutions and businesses to connect between fiat and cryptocurrency. The firm offers its three flagship products:
- FOMO Payment – One-stop digital payment solution for merchants, corporates and financial institutions
- FOMO iBank – Facilitate businesses’ everyday requirements for transactional banking needs
- FOMO Crypto – Asia’s First licensed gateway bridging crypto and fiat
FOMO Pay Official Website Link: https://www.fomopay.com/